Your browser doesn't support javascript.
loading
PARK2 loss promotes cancer progression via redox-mediated inactivation of PTEN.
Gupta, Amit; Anjomani-Virmouni, Sara; Koundouros, Nikos; Poulogiannis, George.
Afiliação
  • Gupta A; Signalling and Cancer Metabolism Team, Division of Cancer Biology, The Institute of Cancer Research, London, UK.
  • Anjomani-Virmouni S; Signalling and Cancer Metabolism Team, Division of Cancer Biology, The Institute of Cancer Research, London, UK.
  • Koundouros N; Signalling and Cancer Metabolism Team, Division of Cancer Biology, The Institute of Cancer Research, London, UK.
  • Poulogiannis G; Division of Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College, London, UK.
Mol Cell Oncol ; 4(6): e1329692, 2017.
Article em En | MEDLINE | ID: mdl-29209642
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Mol Cell Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Mol Cell Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido